A Post-Marketing, Observational, Comparative Safety Study of the Novartis Pandemic Influenza A (H1N1) Vaccine(s) in Pregnant Women Versus Non-Vaccinated Pregnant Women.
Phase of Trial: Phase IV
Latest Information Update: 28 Sep 2011
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions
- Sponsors Novartis; Novartis Vaccines
- 28 Sep 2011 Planned end date changed from 1 Nov 2011 to 1 Nov 2010 as reported by ClinicalTrials.gov.
- 22 Sep 2011 Actual end date Aug 2011 added as reported by ClinicalTrials.gov.
- 22 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.